SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-21-029579
Filing Date
2021-08-27
Accepted
2021-08-27 16:31:50
Documents
14
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc10028425_10ka.htm   iXBRL 10-K/A 50234
2 EXHIBIT 31.1 brhc10028425_ex31-1.htm EX-31.1 9400
3 EXHIBIT 31.2 brhc10028425_ex31-2.htm EX-31.2 9598
  Complete submission text file 0001140361-21-029579.txt   261500

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cycn-20201231.xsd EX-101.SCH 3926
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20201231_lab.xml EX-101.LAB 29918
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20201231_pre.xml EX-101.PRE 21094
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10028425_10ka_htm.xml XML 6854
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38787 | Film No.: 211219321
SIC: 2834 Pharmaceutical Preparations